RADIANCE-II

STUDY IDENTIFIER:

RADIANCE-II

CONDITION:

Hypertension

CONTACT INFO:

Rose Peterson, RN   |   rose.peterson@allina.com   |   612-863-6051

DESCRIPTION:


Hypertension, or high blood pressure, affects over 1 billion people. Left untreated, high blood pressure can increase your risk of serious health problems such as heart attack, stroke, and kidney failure. Yet nearly 1 in 3 individuals with hypertension struggle to control their blood pressure despite being on medication.

If you and your physician have been unable to control your blood pressure, or are interested in an alternative to daily medications, you may be a candidate for the RADIANCE-II Clinical Study. The study is evaluating an investigative minimally-invasive, catheter-based procedure (the Paradise® Renal Denervation System) which may lower your blood pressure and reduce your need for blood pressure medications.

CRITERIA LIST/ QUALIFICATIONS:

  • Age 18 to 75
  • Previously or currently prescribed an antihypertensive medication
  • Average office BP ≥ 140/90 mmHg <180/120 mmHg while stable for at least 4 weeks on 0-2 classes of antihypertensive medication
  • Complete this questionnaire to see if you qualify to participate in the RADIANCE-II Clinical Study.

INVESTIGATORS:

Yale Wang, MD

SPONSORS:

ReCor Medical

STATUS:

Open/Enrolling

Support the research and educational efforts of MHIF

Make a Donation